Ozempic is a prescription medication made by Novo Nordisk and primarily used to treat patients with type 2 diabetes.

Researchers found that the active ingredient in Ozempic may lower the risk of dementia in people with type 2 diabetes.

Ozempic and Mounjaro may also lower your risk of obesity-linked cancer A study found another potential benefit of the weight loss drugs: lowered risk of chronic conditions.